4Sima AA, Sugimoto K. Experimental diabetic neuropathy: an update[J]. Diabetologia, 1999,42(7):773-788.
5Harati Y.Diabetes and the Nervous System[J].Chronic Complications Diabetes, 1996,25(2) :325-359.
6Jnose HN,Jatter PA. Treatment of diabetic neuropathy with r'-lindonic acid[J]. Diabetes Care, 1993,16(2):168.
7Shindo H. Myo-inositol depletion inhibits phosphatidy-imsitol syntsis and turnover and muscarinic-induced cytosolic Ca2+ fluxin in human neuroblastoma cells[J]. Diabetes, 1994,43[Suppl 1]:210A.
8Cameron NE, Cotter MA. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy[J]. Diabetes, 1997, 46 [Suppl 2]: S31-S37.
9Paisey R,Havkness J,Hartog M,et al.The effect of improvement in diabetic control on plasma and whole blood viscosity[J]. Diabetologia,1980,18(3):345-349.
10Srivastava A, Joshi CS, Sethi PPS, et al. Alfered platelet function in non-insulindependent diabetes mellitus[J]. Thuromb Res, 1994, 76(5):451-461.
